MRI
MRI (magnetic resonance imaging) is a diagnostic procedure that combines a powerful magnet, radio waves and computer technology to provide detailed images of tissues, muscles, nerves and bones. Because MRI uses magnetic force and radio waves to create images, there is no radiation exposure during the procedure. MRI is often used instead of CT to study soft tissues or organs because bones do not obscure the organs and soft tissues as they do with CT imaging. DeTar Healthcare System also offers open MRI.
MRI can be used to assess everything from ruptured discs in the spine to detecting brain tumors and vascular diseases through techniques such as breast MRI. Breast MRI can be a more effective imaging technique than mammography for some women, and can provide additional details for diagnosing and evaluating breast abnormalities.
Breast MRI
In addition to mammography, a breast MRI can be an extremely effective screening and diagnostic tool. Breast MRI is often used for women who are at greater risk of developing breast cancer and women with a diagnosis of breast cancer. This technique offers a more comfortable experience for women and is used to:
- Screen high-risk patients
- Assess the extent of breast cancer
- Determine the effectiveness of chemotherapy or radiation therapy during breast cancer treatment
- Further evaluate abnormalities that were found during a mammogram or clinical exam
- Provide additional detail for treatment planning
Am I High Risk?
Certain women are at an increased risk of developing breast cancer. Women who have the following may benefit from earlier and more intensive breast cancer screening, including the use of breast MRI:
- A BRCA1 or BRCA2 gene mutation (and first-degree relatives, but personally have not been tested for BRCA1/2 mutations)
- A personal history of invasive breast cancer or ductal carcinoma in situ (DCIS)
- A personal history of lobular carcinoma in situ (LCIS) or atypical hyperplasia
- Radiation treatment to the chest area between ages 10-30
- Li-Fraumeni, Cowden/PTEN or Bannayan-Riley-Ruvalcaba syndrome (and first-degree relatives)
- An ATM, CDH1, CHEK2, NBN, NF1, PALB2, PTEN, STK11 or TP53 gene mutation
- A greater than 20 percent lifetime risk of invasive breast cancer based mainly on family history.
You can estimate your level of risk by utilizing an online risk assessment calculator, such as the one at cancer.org.
Talk to your primary care provider to determine if you are at increased risk for breast cancer, and would benefit from supplemental breast cancer screening.
To schedule an appointment, please call 361-788-6141.